S5 Ep3: Advancing Myeloma Treatment With Blood-Based MRD Testing
Feb 15, 2024•22 min•Season 5Ep. 3
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In season 5, episode 3 of Targeted Talks, Ben Derman, MD, assistant professor of medicine at the University of Chicago Medical Center, dissects the latest advancements in myeloma treatment, focusing on the role of ClonoSeq and minimal residual disease monitoring.
For the best experience, listen in Metacast app for iOS or Android